Related references
Note: Only part of the references are listed.Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene
Nir Dover et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins
Jason R. Barash et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
Volker Jaeger et al.
BMC BIOTECHNOLOGY (2013)
High Sensitivity ELISA for Detection of Botulinum Neurotoxin Serotype F
Zhijia Liu et al.
HYBRIDOMA (2012)
Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
Torsten Ruelker et al.
PLOS ONE (2012)
Epitope mapping of botulinum neurotoxins light chains
Alexey Zdanovsky et al.
TOXICON (2012)
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin
Siham Chahboun et al.
BMC BIOTECHNOLOGY (2011)
A human scFv antibody generation pipeline for proteome research
Michael Hust et al.
JOURNAL OF BIOTECHNOLOGY (2011)
Phage Display for the Generation of Antibodies for Proteome Research, Diagnostics and Therapy
Thomas Schirrmann et al.
MOLECULES (2011)
Antibodies for biodefense
Jeffrey W. Froude et al.
MABS (2011)
Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies
C. Rasetti-Escargueil et al.
TOXICON (2011)
A VHH That Neutralizes the Zinc Metalloproteinase Activity of Botulinum Neurotoxin Type A
Jeeraphong Thanongsaksrikul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region
Jianbo Dong et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
A comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineering
Philippe Thullier et al.
MABS (2010)
Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents
Jerry O. Conway et al.
PLOS ONE (2010)
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
Thibaut Pelat et al.
BMC BIOTECHNOLOGY (2009)
Antibody Protection against Botulinum Neurotoxin Intoxication in Mice
Luisa W. Cheng et al.
INFECTION AND IMMUNITY (2009)
Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics
Thibaut Pelat et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Non-human primate immune libraries combined with germline humanization An (almost) new, and powerful approach for the isolation of therapeutic antibodies
Thibaut Pelat et al.
MABS (2009)
Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins/A1, /A2, and /A3 by a Panel of Monoclonal Anti-BoNT/A Antibodies
Suzanne R. Kalb et al.
PLOS ONE (2009)
Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus
Mark Schuette et al.
PLOS ONE (2009)
Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: Improved precision with in-bred mice
C. Rasetti-Escargueil et al.
TOXICON (2009)
Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin
Tsuyoshi Takahashi et al.
VACCINE (2009)
Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)
Martina Inga Kirsch et al.
BMC BIOTECHNOLOGY (2008)
Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins
R. G. A. Jones et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering
Thibaut Pelat et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
Sharad P. Adekar et al.
PLOS ONE (2008)
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation
Thibaut Pelat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Genetic diversity among botulinum neurotoxin-producing clostridial strains
K. K. Hill et al.
JOURNAL OF BACTERIOLOGY (2007)
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A
Behzod Z. Dolimbek et al.
MOLECULAR IMMUNOLOGY (2007)
On the influence of vector design on antibody phage display
Glenn Soltes et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A
A Razai et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694
E Laffly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library
S Chassagne et al.
MOLECULAR IMMUNOLOGY (2004)
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
A Nowakowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin
RE Sheridan et al.
TOXICON (2001)
Botulinum toxin as a biological weapon - Medical and public health management
SS Arnon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
A helper phage to improve single-chain antibody presentation in phage display
S Rondot et al.
NATURE BIOTECHNOLOGY (2001)